PPCBライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 04:56):

Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia...

Stats
本日の出来高	3.35M
平均出来高	4.07M
時価総額	3.29B
EPS	$-0.0449 ( 2023-11-14 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.100
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-07-05	Zelinger Josef	Buy	15 000 000	Common Stock Purchase Warrant
2021-08-17	Kenyon Julian Norman	Buy	3 420 000	Common stock, par value $0.001
2021-08-17	Nathanielsz James Andrew	Buy	5 928 000	Common stock, par value $0.001
2021-08-17	Nathanielsz James Andrew	Buy	2 800 000	Common stock, par value $0.001
2021-08-17	Zelinger Josef	Sell	0	Common stock, par value $0.001

INSIDER POWER
100.00
Last 22 transactions
Buy: 280 061 820 \| Sell: 580 500

Propanc Biopharma, Inc. 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Propanc Biopharma, Inc. 財務諸表

Annual	2023
収益:	$0
総利益:	$-28 841.00 (0.00 %)
EPS:	$-1.530

FY	2023
収益:	$0
総利益:	$-28 841.00 (0.00 %)
EPS:	$-1.530

FY	2022
収益:	$0
総利益:	$-28 366.00 (0.00 %)
EPS:	$-1.530

FY	2021
収益:	$0.00
総利益:	$0.00 (0.00 %)
EPS:	$-0.800

Financial Reports:

No articles found.

Propanc Biopharma, Inc.

Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.